PCS
EXAS

Personal CFO Solutions’s Exact Sciences EXAS Stock Holding History

Personal CFO Solutions’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,736
Closed -$204K – 512
2025
Q3 		$204K Buy
+3,736
New +$187K 0.04% 486
2024
Q4 		– Sell
-2,984
Closed -$203K – 507
2024
Q3 		$203K Buy
+2,984
New +$168K 0.03% 533
2024
Q2 		– Sell
-3,004
Closed -$207K – 555
2024
Q1 		$207K Sell
3,004
-151
-5% -$9.55K 0.03% 516
2023
Q4 		$233K Buy
+3,155
New +$207K 0.04% 447
2023
Q3 		– Sell
-2,411
Closed -$226K – 477
2023
Q2 		$226K Buy
+2,411
New +$188K 0.05% 416

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Personal CFO Solutions's EXAS Position: Q4 2025 in Review

Personal CFO Solutions sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 3,736 shares — an estimated $204K sold.

Personal CFO Solutions first reported a position in EXAS in Q2 2023 and held it in 5 quarters. The position peaked at $233K in Q4 2023. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Personal CFO Solutions reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Personal CFO Solutions sold 3,736 Exact Sciences shares in Q4 2025, an estimated $204K.
  • Personal CFO Solutions first reported a position in Exact Sciences in Q2 2023 and held it in 5 quarters.
  • Personal CFO Solutions's Exact Sciences position peaked at $233K in Q4 2023.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Personal CFO Solutions's 13F filing for Q4 2025, filed 22 Jan 2026.